Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Goggins - your are obviously someone who takes the p**ss as a matter of course. Only part of Illuminas patent was infringed from what I can remember, so the appeal court could have quite easily taken us into a completely different direction on that point. Regardless of this fact, the BOD has led this company into the formation of an internationally accepted group through the most adverse conditions, under the constraints of litigation both contractually and financially. During this time they have conducted all business dealings and acquisitions with the full backing of one of the largest pharmaceutical companies in the world, who stood by Premaitha from the outset (so much for their thoughts on infringement). Are you also saying Genoma going bust was their fault. My god, I think I've heard everything. Putting all that aside, I join you in the disappointment of the markets reluctance to move the price after the settlement, however, your bitterness should not allow your thoughts to be twisted away from a positive outcome. I am very much convinced of Premaitha's success, we just have to be patient.
Patents are virtually always down to interpretation, what is deemed expected knowledge of a professional working in that domain etc etc ... We were unlucky, it could equally have gone the other way as had previous cases...
If there was a low cost agreement / licence available earlier, I’m sure the BOD would have taken it so presumably Illumina just wanted to be distruptive ... The BOD did will with yourgene as an attempt to diversify geographically ...
The fincap f’ up ... well, at least AR pulled us back from th 7p brink... it could’ve been a lot worse otherwise. There’s no way we would got a raising away at the 15p spike - would anyone chuck in £3m at a spike?
Yep, I am a LTH at roughly B/E, it’s been painful, very painful at times but we should now see the revenue grow ...
Is anyone attending the AGM?
Yes because infringing on another companies patents, getting screwed out of nearly a million quid by genoma and seeing the SP go down to 3p and allowing finncapp to f up the most recent placing is brilliant management of the company isn't it? I applaud the BOD for dilution and being less than listing price.
Us LTHs are not happy because we are fully aware of the omnishambles this company has been thus far.
I can't believe I'm hearing all this. You all are supposedly LTH's with full knowledge of how the company operates but talk as if you are newcomers with grievances against the BOD because the price has just dropped 30 points. I told you all the price would challenge 9p as part of the placing phase so this is not unexpected, and there is nothing wrong with this drop if you know what the reason for the temporary drop is. You've got to admit, we were all definitely taken aback by the way the settlement deal was announced. Took everyone by surprise including the BOD. £1m for the settlement left them with £300,000, insufficient to operate the business, so the placing was the inevitable consequence. To sum up, the BOD achieved the deal we all hoped for and were then forced into a placing because of it. Maybe someone could explain how this should have been handled differently..
To some extent I agree with TW, options are an incentive to drive the company forward, however that's about as far as I agree on this point. When a director is offered options the company isn't at that point giving anything away. In fact in this case Jeffrieys 10p shares could be undercut by purchasing them at 9.5p today. If on the other hand the price increases to 20p, he then has the option to purchase at 10p, and to be honest, who gives a hoot if he does. The company has performed well enough to raise the market price to 20p, so why not, he's done his job, I'm also sitting at 20p and have made the same profit as he has, what's the fuss. Maybe we should all think about how this guy got to the position with which the opportunity arose to get the options, instead of bashing anyone who might be seen as getting an incentivised freeby.
Agreed notaflip .. We were waiting so long for the settlement and now we have it .. the big fat elephant has gone. We also have another non-NIPT revenue stream starting up.
Just need a little sentiment to return and we'll be off!
Despite the sp we just need to keep things is perspective...
Mid-to long terms what has not been mentioned is that 2 billion dollar companies now have a stake in this company. TMO have circa 20% on a diluted basis in warrants at 24p. So that's the floor mid to long term in the event of a TO. And as the IONA test is the only CE-IVD test that is designed to works on a TMO sequencer there will be a buyer.
At present a 6% dilution has caused a nearly 40% drop in sp. That is somewhat unnecessary even if we allowed that further cash may be required. The reason why I expect this was unfortunately left to uncertainty is that this funding could come through alternative means rather than equity issue, may not be required if sales improve post settlement and that the company expect further news will mean that this will be done at a much higher price resulting in much less dilution. I still hold that I believe that news should come pre-AGM for some reasons given
The company is now trading below levels than when it had far more uncertainty around royalty payments, legal costs, trading opportunities in US/UK/EU and had few products. This is somewhat incredible and frustrating to say the least. But we keep perspective and also mindful that further news is coming.
P.S. Unfortunately also swing trading is a bit more difficult if your holdings are of any significance.
true if you like to play that game been a great trading/traders share probably best way to play this company if funds allow and you know how trade
as a mid to long term investment I have grave concerns
Calm down ...mkt reacting to likely further raises ...that.s it. Hopefully sales can pick up, with the likes of India helping us out. New business v new raises ...the only equation for me. GLA ...relax.
Kezz, ironically you could have picked some up even cheaper at 4.35p at the time too!
Is there anything they haven't fcked up
still unconvinced with these muppets going forward until proven otherwise
lets not forget the 4.5p placing which was a disgrace
been one big gravy grain that could still end up going tits up
So much for the new boss! Even if finncap messed up, we never looked to include pi's and option award at 10p us an insult! I always say this, but when news comes judt before agm if usual service is delivered , it would still serve to hold bod to account on this and ask if this year's doubtless spun and promise for progress and news will see sp taking note as its been said each year along with a lower sp!!
You are 100% correct.
Only these could cock it up so bad - I don't know how they sleep at night. Clowns.
It's an utter disgrace that the SP has fallen nigh on 40% from the settlement need we have waited for. The way they handled it is shambolic. Utterly shambolic.
Only this lot could f up the settlement news and a new product with a placing at 10p when the shares where 15p
Hopefully this suggests, in addition to the other reasons given, that there may be further news in the next 2 weeks as the BoD will be wanting to give themselves an easier time given how peeved LTHs are over how things have been managed since the settlement.
TW Latest...……….…………Tom Winnifrith Bearcast: Next stop for Musk & Tesla ( jail & $0?) & what really happened at Premaitha will shock you""
TW latest,... I am looking forward to grilling Premaitha (NIPT) at the Nigel Wray London seminar on 16 October. There are still a few places going and its free – details HERE. Meanwhile we have three pieces of news this week following that rather disappointing placing at 10p two Friday's ago caused by the a’hole behaviour of the toads at FinnCap. Yes this is Tom Winnifrith writing… The very good news is that the group’s Yourgene Bioscience division has signed a deal with a “leading clinical research organisation in Taiwan” to deliver next generation sequencing (NGS) testing in oncology.Under the terms of the partnership, Yourgene will provide genetic testing services using NGS technology on patient samples gathered by the Partner for the purpose of research into early stage cancer screening. We are told that this is the first phase of collaboration between Yourgene and the Partner and further project phases are anticipated in the future. The initial phase is anticipated to generate approximately $1 million of revenues over the next 6-12 months. Well that all helps the drive towards break-even. A few more deals like this will do no harm at all. We also had some director dealings. First up Barry Hextall bought 100,000 shares at 10p. It is not much but I suppose better than nothing. Following the acquisition, Mr Hextall's beneficial interest in the Company is 432,518 ordinary shares, 0.1% of the issued share capital. We are also told that: ”In addition, further to the appointment of Hayden Jeffreys to the Board announced 3 October 2018, Mr Jeffreys has been awarded share options over 3,000,000 ordinary shares, exercisable at 10 pence per share subject to the existing Company scheme rules.” Ends. This makes me angry. Over at Optibiotix (OPTI) options vest at a 100% premium to the share price at issue. That is an incentive. Options are meant to be an incentive. Premaitha options seem to v est at a share price which has been dragged low by in-house incompetence. This is not an incentive. If Premaitha’s share price just matches inflation of. Say 2%, then in five years this is a free £30,000 for lucky Hayden who will not have had to risk a cent. We shareholders who risk our capital would have, uncder this scenario, have underperformed the market big time and in real terms be no better off at all. Such option programmes steal wealth from those who risk capital and transfer it to those who do not, management fat cats. This is just not acceptable. And it is one reason why folks respect the board at Optibiotiox while, right now, thinking Premaitha is run by a bunch of a’holes. Notwithstanding this, another matter I plan to raise on the 16th, the stance remains BUY with a target to sell of c21p.
Seems like TW has support for NIPT at the moment, mind you he did for Big Sofa too. Just pleased for LTH here that IMHO they were in on the recent rise, from lows that nobody saw.
I haven"t got a position here, but GL those that have, there is much to like about the potential here. ATVB.
Premaitha Health have been trading as YourGene Health outside of EU since the May 2018 RNS where this has already been communicated to shareholders. However the Proxy Form special resolution is asking for shareholders to approve this change formally and introduce the YourGene Health brand, initially outside Europe and Taiwan, as this branding is more internationally applicable and reflects their strategy of broadening the range of products (already 3 ~ potentially 5 by end of year with more to come) they will be offering. Hence suggesting that there will be further explanations of this strategy to shareholders before the AGM on the new CEO's strategic vision.
To change company name ! Looks like it's being voted on at AMG.
Florida ... no worries. Thnx for your good posts. Tk care.
Can anyone answer the following? Why was the placing done in two tranches? Why did the directors subscribe only at the time of the second tranche? Finncap organized the placing jointly and will be paid for it but I thought Reynolds had sorted this himself because Finncap were useless? Why did Barry Hextall not participate in the placing and buy shares on the open market instead? Thanks
Boyzee - not sure why your getting a bee in your bonnet. I thought I was pretty clear and no accusations to anyone in particular, certainly not you. If you are suffering from an inate guilt complex that's your problem to overcome. However, I repeat, there are a number of negative posters and there will be more.
Flipper - like your idea about a relaunch on the 25th. With litigation over it is essential the international community see's this company in a new light. We need to start claiming back all those near misses by opening a new paragraph in the book of Premaitha. However, can't see any benefit to issuing other news before the submission date. We do need reasons to push the price forward but not when we are locked into a placing phase.
At least he.s trying ...
We all hope to be so for all ourselves Twix
My understanding though is that 02-Jul-15 Barry Kenneth Hextall bought 150,000 @ 20p in addition to the 17-Dec-15
180,736 purchase you reference @ 18.03.
Incidentally I believe he has 5,000,000 options @ 20p but IR can confirm the executable price.
Hopefully now everyone has loaded up, and strapped in, we can continue the uptrend and pass quickly where we dropped off soon.
£10k from a bean counter is hardly a shiny endorsement purchase.but every little helps.
And welcome aboard to the options gravy train for our latest director recruit. Look forward to the BOD tackling head-on the soaring admin charges currently crippling the accounts.